3[3]Tikkanen MJ, Nikkila EA, Kuusi T, et al. High density lipoprotein2 and hepatic lipase:reciprocal changes produce by estrogen and norgestrel. J Cli Endocrinol Metabol, 1982,54:1113～1117.
4[4]Folson AR, Mink PJ, Sellers TA, et al. Hoemonal replaecment therapy and morbidity and mortality in prospective study of postmenopausal women. Am J Publi Health, 1995,85:1128～1132.
二级参考文献4
1Koren E.Triglyceride enriched lipoprotein particles correlates with the severity of coronary artery disease.Atherosclerosis,1996,122:105.
2The Scandinavian simvasta tin Survival Study Group.Lancet,1994,334:1383～1389.
3Forman BM,chen J.Evans RM.Hypolipidemic drugs,polyunsaturated fatty acids,and eicosanoids are ligands for peroxisome proliferator activated receptors a and ε.Proc Natl Acad sci USA,1997,94:4312～4317.
4Ericsson CG,Hamsten A,Nilsson,Grip L,svane B,de Faire U.Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male post infarctin patients.Lancet,1996,347:849～853.
1Tikkanen MI,Nikkila EA,Kuusi T,et al.High density lipoprotein2 and hepatic lipase:reciprocal changes produce by estrogen and norgestrel[J].J Clin Endocrinol Metabol,1982,54:1113-1117.
